Dr. Alison Fleming was appointed Chief Technology Officer in 2017. Dr. Fleming first joined Collegium Pharmaceutical in 2002, shortly after completing her Ph.D. in the School of Chemical and Biomolecular Engineering at Cornell University. Prior to joining Collegium, her academic research focused on implantable drug delivery systems for cancer therapy. Dr. Fleming is an inventor on several United States Patents and pending patent applications and has authored numerous scientific publications and poster presentations in the field of novel drug delivery systems. She received her B.S. degree in Chemical Engineering from the University of Massachusetts, Amherst.